Draft Guidance Document - Disclosure of Confidential Business Information under Paragraph 21.1(3)(c) of the Food and Drugs Act

Health Canada is pleased to announce the release of the Draft Guidance Document – “Disclosure of Confidential Business Information under Paragraph 21.1(3)(c) of the Food and Drugs Act” for a 75-day stakeholder consultation.

How to Get Involved

This consultation is open for comment starting March 10, 2016 until May 24, 2016. Please select and read through the link below titled “consultation document”. Once read please submit your comments via email, fax or by mail to:

rmod_stakeholders-intervenants_dgro@hc-sc.gc.ca

Resource Management and Operations Directorate
Health Canada
5th Floor, Room 545
Address Locator 20051
Graham Spry Building
250 Lanark Avenue
Ottawa, Ontario
K1A 0K9
Telephone: 613-219-1574

Consultation Document

Interested parties are encouraged to provide comments and suggestions by May 24, 2016.

Reporting to Canadians

Health Canada will make the results of this consultation available on this web site.

If you have any questions, contact us at Resource Management and Operations Directorate.

Interested in our other consultations? Sign up and stay informed about topics that matter to you.